Skip to menu Skip to content Skip to footer

2019

Journal Article

Diagnosis of primary aldosteronism by seated saline suppression test - variability between immunoassay and HPLC-MS/MS

Thuzar, Moe, Young, Karen, Ahmed, Ashraf H., Ward, Greg, Wolley, Martin, Guo, Zeng, Gordon, Richard D., McWhinney, Brett C., Ungerer, Jacobus P. and Stowasser, Michael (2019). Diagnosis of primary aldosteronism by seated saline suppression test - variability between immunoassay and HPLC-MS/MS. Journal of Clinical Endocrinology and Metabolism, 105 (3) dgz150, e477-e483. doi: 10.1210/clinem/dgz150

Diagnosis of primary aldosteronism by seated saline suppression test - variability between immunoassay and HPLC-MS/MS

2019

Journal Article

Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism (vol 103, pg 3965, 2018)

Guo, Z., Poglitsch, M., McWhinney, B. C., Ungerer, J. P. J., Ahmed, A. H., Gordon, R. D., Wolley, M. and Stowasser, M. (2019). Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism (vol 103, pg 3965, 2018). Journal of Clinical Endocrinology & Metabolism, 104 (6), 2054-2056. doi: 10.1210/jc.2019-00527

Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism (vol 103, pg 3965, 2018)

2019

Journal Article

Response to letter to the editor: "Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism"

Stowasser, Michael, Guo, Zeng, Ahmed, Ashraf, Wolley, Martin and Gordon, Richard D. (2019). Response to letter to the editor: "Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism". The Journal of Clinical Endocrinology and Metabolism, 104 (6), 2344-2345. doi: 10.1210/jc.2019-00179

Response to letter to the editor: "Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism"

2019

Journal Article

Pathogenesis of familial hyperaldosteronism type II: new concepts involving anion channels

Stowasser, Michael, Wolley, Martin, Wu, Aihua, Gordon, Richard D., Schewe, Julia, Stoelting, Gabriel and Scholl, Ute I. (2019). Pathogenesis of familial hyperaldosteronism type II: new concepts involving anion channels. Current Hypertension Reports, 21 (4) 31, 31. doi: 10.1007/s11906-019-0934-y

Pathogenesis of familial hyperaldosteronism type II: new concepts involving anion channels

2019

Journal Article

Mineralocorticoid antagonism enhances brown adipose tissue function in humans: a randomized placebo-controlled cross-over study

Thuzar, Moe, Law, W. Phillip, Dimeski, Goce, Stowasser, Michael and Ho, Ken K. Y. (2019). Mineralocorticoid antagonism enhances brown adipose tissue function in humans: a randomized placebo-controlled cross-over study. Diabetes, Obesity and Metabolism, 21 (3), 509-516. doi: 10.1111/dom.13539

Mineralocorticoid antagonism enhances brown adipose tissue function in humans: a randomized placebo-controlled cross-over study

2019

Journal Article

The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway

Wu, Aihua, Wolley, Martin and Stowasser, Michael (2019). The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway. Journal of Human Hypertension, 33 (7), 508-523. doi: 10.1038/s41371-019-0170-6

The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway

2018

Journal Article

Aldosterone LC-MS/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism

Guo, Zeng, Poglitsch, Marko, McWhinney, Brett C., Ungerer, Jacobus P. J., Ahmed, Ashraf H., Gordon, Richard D., Wolley, Martin and Stowasser, Michael (2018). Aldosterone LC-MS/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism. Journal of Clinical Endocrinology and Metabolism, 103 (11), 3965-3973. doi: 10.1210/jc.2018-01041

Aldosterone LC-MS/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism

2018

Journal Article

Cellular and genetic causes of idiopathic hyperaldosteronism

Omata, Kei, Satoh, Fumitoshi, Morimoto, Ryo, Ito, Sadayoshi, Yamazaki, Yuto, Nakamura, Yasuhiro, Anand, Sharath K., Guo, Zeng, Stowasser, Michael, Sasano, Hironobu, Tomlins, Scott A. and Rainey, William E. (2018). Cellular and genetic causes of idiopathic hyperaldosteronism. Hypertension, 72 (4), 874-880. doi: 10.1161/HYPERTENSIONAHA.118.11086

Cellular and genetic causes of idiopathic hyperaldosteronism

2018

Journal Article

Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism

Stowasser, Michael, Ahmed, Ashraf H., Cowley, Diane, Wolley, Martin, Guo, Zeng, McWhinney, Brett C., Ungerer, Jacobus P. and Gordon, Richard D. (2018). Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism. The Journal of Clinical Endocrinology and Metabolism, 103 (11), 4113-4124. doi: 10.1210/jc.2018-01394

Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism

2018

Journal Article

A young man with severe hypertension

Tan, Jin Ern, Wu, Danielle and Stowasser, Michael (2018). A young man with severe hypertension. BMJ, 362 k2935, k2935. doi: 10.1136/bmj.k2935

A young man with severe hypertension

2018

Journal Article

Is it time to screen all patients with hypertension for primary aldosteronism?

Yang, Jun, Fuller, Peter J. and Stowasser, Michael (2018). Is it time to screen all patients with hypertension for primary aldosteronism?. Medical Journal of Australia, 209 (2), 57-59. doi: 10.5694/mja17.00783

Is it time to screen all patients with hypertension for primary aldosteronism?

2018

Journal Article

Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism

Williams, Tracy A., Burrello, Jacopo, Sechi, Leonardo A., Fardella, Carlos E., Matrozova, Joanna, Adolf, Christian, Baudrand, René, Bernardi, Stella, Beuschlein, Felix, Catena, Cristiana, Doumas, Michalis, Fallo, Francesco, Giacchetti, Gilberta, Heinrich, Daniel A., Saint-Hilary, Gaëlle, Jansen, Pieter M., Januszewicz, Andrzej, Kocjan, Tomaz, Nishikawa, Tetsuo, Quinkler, Marcus, Satoh, Fumitoshi, Umakoshi, Hironobu, Widimský, Jiří, Hahner, Stefanie, Douma, Stella, Stowasser, Michael, Mulatero, Paolo and Reincke, Martin (2018). Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism. Hypertension, 72 (3), HYPERTENSIONAHA.118.11382-649. doi: 10.1161/HYPERTENSIONAHA.118.11382

Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism

2018

Journal Article

CLCN2 chloride channel mutations in familial hyperaldosteronism type II

Scholl, Ute I., Stölting, Gabriel, Schewe, Julia, Thiel, Anne, Tan, Hua, Nelson-Williams, Carol, Vichot, Alfred A., Jin, Sheng Chih, Loring, Erin, Untiet, Verena, Yoo, Taekyeong, Choi, Jungmin, Xu, Shengxin, Wu, Aihua, Kirchner, Marieluise, Mertins, Philipp, Rump, Lars C., Onder, Ali Mirza, Gamble, Cory, McKenney, Daniel, Lash, Robert W., Jones, Deborah P., Chune, Gary, Gagliardi, Priscila, Choi, Murim, Gordon, Richard, Stowasser, Michael, Fahlke, Christoph and Lifton, Richard P. (2018). CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nature Genetics, 50 (3), 1-6. doi: 10.1038/s41588-018-0048-5

CLCN2 chloride channel mutations in familial hyperaldosteronism type II

2017

Journal Article

ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II)

De Sousa, S. M. C., Stowasser, M., Feng, J., Schreiber, A. W., Wang, P., Hahn, C. N., Gordon, R. D., Torpy, D. J., Scott, H. S. and Gagliardi, L. (2017). ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II). Journal of Human Hypertension, 31 (12), 857-859. doi: 10.1038/jhh.2017.71

ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II)

2017

Journal Article

The SPARTACUS Trial: Controversies and Unresolved Issues

Beuschlein, Felix, Mulatero, Paolo, Asbach, Evelyn, Monticone, Silvia, Catena, Cristiana, Sechi, Leonardo A and Stowasser, Michael (2017). The SPARTACUS Trial: Controversies and Unresolved Issues. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 49 (12), 936-942. doi: 10.1055/s-0043-120524

The SPARTACUS Trial: Controversies and Unresolved Issues

2017

Journal Article

Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?

Stowasser, Michael, Ahmed, Ashraf, Guo, Zeng, Wolley, Martin, Ungerer, Jacobus, McWhinney, Brett, Poglitsch, Marko and Gordon, Richard (2017). Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?. Hormone and Metabolic Research, 49 (12), 915-921. doi: 10.1055/s-0043-121468

Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?

2017

Journal Article

Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort

Williams, Tracy A., Lenders, Jacques W. M., Mulatero, Paolo, Burrello, Jacopo, Rottenkolber, Marietta, Adolf, Christian, Satoh, Fumitoshi, Amar, Laurence, Quinkler, Marcus, Deinum, Jaap, Beuschlein, Felix, Kitamoto, Kanako K., Pham, Uyen, Morimoto, Ryo, Umakoshi, Hironobu, Prejbisz, Aleksander, Kocjan, Tomaz, Naruse, Mitsuhide, Stowasser, Michael, Nishikawa, Tetsuo, Young, William F., Jr., Gomez-Sanchez, Celso E., Funder, John W. and Reincke, Martin (2017). Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes & Endocrinology, 5 (9), 689-699. doi: 10.1016/S2213-8587(17)30135-3

Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort

2017

Journal Article

Targeted LOWering of Central Blood Pressure in patients with hypertension: Baseline recruitment, rationale and design of a randomized controlled trial (The LOW CBP study)

Sharman, James E., Stanton, Tony, Reid, Christopher M., Keech, Anthony, Roberts-Thomson, Philip, Stewart, Simon, Greenough, Robert, Stowasser, Michael and Abhayaratna, Walter P. (2017). Targeted LOWering of Central Blood Pressure in patients with hypertension: Baseline recruitment, rationale and design of a randomized controlled trial (The LOW CBP study). Contemporary Clinical Trials, 62, 37-42. doi: 10.1016/j.cct.2017.08.010

Targeted LOWering of Central Blood Pressure in patients with hypertension: Baseline recruitment, rationale and design of a randomized controlled trial (The LOW CBP study)

2017

Journal Article

Facebook advertising for participant recruitment into a blood pressure clinical trial

Nash, Erin L., Gilroy, Deborah, Srikusalanukul, Wichat, Abhayaratna, Walter P., Stanton, Tony, Mitchell, Geoffrey, Stowasser, Michael and Sharman, James E. (2017). Facebook advertising for participant recruitment into a blood pressure clinical trial. Journal of Hypertension, 35 (12), 2527-2531. doi: 10.1097/HJH.0000000000001477

Facebook advertising for participant recruitment into a blood pressure clinical trial

2017

Journal Article

Effect of moxonidine on the aldosterone/renin ratio in healthy male volunteers

Ahmed, Ashraf H., Gordon, Richard D., Ward, Gregory, Wolley, Martin, McWhinney, Brett C., Ungerer, Jacobus P. and Stowasser, Michael (2017). Effect of moxonidine on the aldosterone/renin ratio in healthy male volunteers. Journal of Clinical Endocrinology & Metabolism, 102 (6), 2039-2043. doi: 10.1210/jc.2016-3821

Effect of moxonidine on the aldosterone/renin ratio in healthy male volunteers